---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-028489"
form_type: "8-K"
ticker: "NRXS"
cik: "0001933567"
company_name: "Neuraxis, INC"
filed_at: "2026-06-12T20:50:36+00:00"
generated_at: "2026-06-12T20:58:08.460630+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Neuraxis stockholders elect all six director nominees, approve equity plan amendments at annual meeting

## Summary
- Six director nominees elected: Brian Carrico, Dr. Christopher R Brown, Bradley Mitch Watkins, Beth Keyser, Kristen Ferge, Dr. Gilad Aharon; each received 96-99% of votes.
- Ratification of Rosenberg Rich Baker Berman as independent auditor for FY 2026 approved (10,187,191 votes for, 0 against, 16,815 abstentions).
- Third amendment to Neuraxis 2022 Omnibus Securities and Incentive Plan (solely Section 5.1) approved with 6,730,816 votes for, 727,030 against.
- Neuraxis 2025 Employee Stock Purchase Plan approved as amended; Section 5(c) changed to 10% ownership limit from 5%.

## SEC filing metadata
- accession: 0001493152-26-028489
- form_type: 8-K
- ticker: NRXS
- cik: 0001933567
- company_name: Neuraxis, INC
- filed_at: 2026-06-12T20:50:36+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1933567/000149315226028489/0001493152-26-028489-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1933567/000149315226028489/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-028489
- JSON: https://secwatch.observer/filing/0001493152-26-028489.json
- Plain text: https://secwatch.observer/filing/0001493152-26-028489.txt

## Key facts
- Shareholder Votes
  Neuraxis, INC shareholders approved Amendment to Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan at the 2026-06-10 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: 3. The proposal regarding the amendment to Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan was approved as follows:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1933567/000149315226028489/0001493152-26-028489-index.htm
- Shareholder Votes
  Neuraxis, INC shareholders approved Approval of Neuraxis, Inc. 2025 Employee Stock Purchase Plan at the 2026-06-10 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: 4. The proposal regarding the Neuraxis, Inc. 2025 Employee Stock Purchase Plan was approved as follows:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1933567/000149315226028489/0001493152-26-028489-index.htm
- Shareholder Votes
  Neuraxis, INC shareholders approved Ratification of appointment of Rosenberg Rich Baker Berman, P.A. as independent registered public accounting firm at the 2026-06-10 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: 2. The proposal to ratify the appointment of Rosenberg Rich Baker Berman, P.A. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved as follows:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1933567/000149315226028489/0001493152-26-028489-index.htm
- Shareholder Votes
  Neuraxis, INC shareholders approved Election of six nominees for director at the 2026-06-10 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: 1. The six nominees for director were elected to serve a one-year term as follows:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1933567/000149315226028489/0001493152-26-028489-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.